120% Immediate Hydration

35% Neocollagenesis Increase

Biotechnological Performance Metrics

• Transepidermal Water Loss (TEWL): Reduced by 28% within 72 hours of initial application.

• Fibroblast Activation: Exosomal signaling increases metabolic activity in dermal fibroblasts by 300%.

• DNA Repair: PDRN fragments (Salmon DNA) provide nitrogenous bases for rapid tissue regeneration.

• Elasticity Index: Significant improvement of 45% recorded over a 3-week clinical cycle.

CMK Laboratory Certified

Study ID: CMK-2023-HAX

Sample Size: 150 Participants

Duration: 8-Week Longitudinal Study

Phase: Preparation

Decontaminate skin using a non-abrasive pH-balanced tonic. Ensure the dermal barrier is receptive but not compromised.

Phase: Administration

Apply the 2.5ml ampoule in its entirety. Optimal delivery via topical absorption on damp skin or professional MTS (Microneedle Therapy System).

Phase: Maintenance

Maintain 3-5 week intervals between cycles. Store unsealed units in a climate-controlled environment below 15°C.

Professional Safety Standards

Contraindicated for patients presenting with active rosacea, impetigo, or localized viral infections. Post-procedure erythema is expected to resolve within 2-4 hours.

Ingredients Transparency (E-E-A-T Compliance)

• Medical-Grade Sodium Hyaluronate

• Hydrolyzed Salmon DNA (PDRN 98.3%)

• Centella Asiatica Derived Exosomes

• Biomimetic Peptide Complex (sh-Oligopeptide-1)